134 related articles for article (PubMed ID: 35245453)
1. How to resist Notch-targeted T-leukemia therapy: Lineage- and MYC enhancer switch.
Bayer M; Grosschedl R
Mol Cell; 2022 Mar; 82(5):884-886. PubMed ID: 35245453
[TBL] [Abstract][Full Text] [Related]
2. The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia.
Choi SH; Severson E; Pear WS; Liu XS; Aster JC; Blacklow SC
PLoS One; 2017; 12(10):e0185762. PubMed ID: 29023469
[TBL] [Abstract][Full Text] [Related]
3. Notch in Leukemia.
McCarter AC; Wang Q; Chiang M
Adv Exp Med Biol; 2018; 1066():355-394. PubMed ID: 30030836
[TBL] [Abstract][Full Text] [Related]
4. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.
Yashiro-Ohtani Y; Wang H; Zang C; Arnett KL; Bailis W; Ho Y; Knoechel B; Lanauze C; Louis L; Forsyth KS; Chen S; Chung Y; Schug J; Blobel GA; Liebhaber SA; Bernstein BE; Blacklow SC; Liu XS; Aster JC; Pear WS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E4946-53. PubMed ID: 25369933
[TBL] [Abstract][Full Text] [Related]
5. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.
Sanchez-Martin M; Ferrando A
Blood; 2017 Mar; 129(9):1124-1133. PubMed ID: 28115368
[TBL] [Abstract][Full Text] [Related]
6. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia.
Herranz D; Ambesi-Impiombato A; Palomero T; Schnell SA; Belver L; Wendorff AA; Xu L; Castillo-Martin M; Llobet-Navás D; Cordon-Cardo C; Clappier E; Soulier J; Ferrando AA
Nat Med; 2014 Oct; 20(10):1130-7. PubMed ID: 25194570
[TBL] [Abstract][Full Text] [Related]
7. MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
Pajcini KV; Xu L; Shao L; Petrovic J; Palasiewicz K; Ohtani Y; Bailis W; Lee C; Wertheim GB; Mani R; Muthusamy N; Li Y; Meijerink JPP; Blacklow SC; Faryabi RB; Cherry S; Pear WS
Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138297
[TBL] [Abstract][Full Text] [Related]
8. Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL.
Gordon WR; Roy M; Vardar-Ulu D; Garfinkel M; Mansour MR; Aster JC; Blacklow SC
Blood; 2009 Apr; 113(18):4381-90. PubMed ID: 19075186
[TBL] [Abstract][Full Text] [Related]
9. High selective pressure for Notch1 mutations that induce Myc in T-cell acute lymphoblastic leukemia.
Chiang MY; Wang Q; Gormley AC; Stein SJ; Xu L; Shestova O; Aster JC; Pear WS
Blood; 2016 Nov; 128(18):2229-2240. PubMed ID: 27670423
[TBL] [Abstract][Full Text] [Related]
10. Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias.
Rakowski LA; Garagiola DD; Li CM; Decker M; Caruso S; Jones M; Kuick R; Cierpicki T; Maillard I; Chiang MY
Cancer Res; 2013 Jan; 73(2):930-41. PubMed ID: 23161489
[TBL] [Abstract][Full Text] [Related]
11. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
12. High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling.
Medyouf H; Gusscott S; Wang H; Tseng JC; Wai C; Nemirovsky O; Trumpp A; Pflumio F; Carboni J; Gottardis M; Pollak M; Kung AL; Aster JC; Holzenberger M; Weng AP
J Exp Med; 2011 Aug; 208(9):1809-22. PubMed ID: 21807868
[TBL] [Abstract][Full Text] [Related]
13. Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation.
Kong G; Du J; Liu Y; Meline B; Chang YI; Ranheim EA; Wang J; Zhang J
J Biol Chem; 2013 Jun; 288(25):18219-27. PubMed ID: 23673656
[TBL] [Abstract][Full Text] [Related]
14. Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL.
Antoszewski M; Fournier N; Ruiz Buendía GA; Lourenco J; Liu Y; Sugrue T; Dubey C; Nkosi M; Pritchard CEJ; Huijbers IJ; Segat GC; Alonso-Moreno S; Serracanta E; Belver L; Ferrando AA; Ciriello G; Weng AP; Koch U; Radtke F
Blood; 2022 Apr; 139(16):2483-2498. PubMed ID: 35020836
[TBL] [Abstract][Full Text] [Related]
15. T-ALL pathogenesis requires a NOTCH1-driven MYC enhancer.
Cancer Discov; 2014 Nov; 4(11):OF17. PubMed ID: 25367958
[TBL] [Abstract][Full Text] [Related]
16. Recent advances on NOTCH signaling in T-ALL.
Tzoneva G; Ferrando AA
Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746
[TBL] [Abstract][Full Text] [Related]
17. Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia.
Xi M; Guo S; Bayin C; Peng L; Chuffart F; Bourova-Flin E; Rousseaux S; Khochbin S; Mi JQ; Wang J
Front Med; 2022 Jun; 16(3):442-458. PubMed ID: 34669156
[TBL] [Abstract][Full Text] [Related]
18. An activating intragenic deletion in NOTCH1 in human T-ALL.
Haydu JE; De Keersmaecker K; Duff MK; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Ferrando A
Blood; 2012 May; 119(22):5211-4. PubMed ID: 22510873
[TBL] [Abstract][Full Text] [Related]
19. A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies.
Ortega M; Bhatnagar H; Lin AP; Wang L; Aster JC; Sill H; Aguiar RC
Leukemia; 2015 Apr; 29(4):968-76. PubMed ID: 25311243
[TBL] [Abstract][Full Text] [Related]
20. Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress.
Melnick AF; Mullin C; Lin K; McCarter AC; Liang S; Liu YE; Wang Q; Jerome NA; Choe E; Kunnath N; Bodanapu G; Akter F; Magnuson B; Kumar S; Lombard DB; Muntean AG; Ljungman M; Sekiguchi J; Ryan RJH; Chiang MY
Blood; 2023 Dec; 142(25):2159-2174. PubMed ID: 37616559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]